Alisa N. Femia, MD

  • Specialty: Dermatology
  • Language: English
  • Phone: 212-263-5015

About Me

Conditions and Treatments

connective tissue disease, dermatomyositis, cutaneous lupus erythematosus, scleroderma, sarcoidosis, vitiligo, eczema, hives, acne, atopic dermatitis, morphea, panniculitis, chilblains, raynaud's disease
Show More Conditions

Credentials

Positions
  • Assistant Professor, Ronald O. Perelman Department of Dermatology
Board Certifications
  • American Board of Dermatology - Dermatology, 2012
Education and Training
  • Residency, SUNY at Stony Brook, Dermatology, 2012
  • MD from SUNY - Stony Brook, 2008
Departments

Locations and Appointments

33 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • HealthRepublic
  • HealthSmart (WTC)
  • Humana Medicare
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MultiPlan/PHCS PPO
  • NYS Empire Plan
  • Oscar
  • Oxford Medicare
  • UPN Elite
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Visiting Nurse Service (VNS) Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYU Dermatologic Associates

240 East 38th Street, 12th Floor
New York, NY 10016

Contact

Phone: 212-263-5015

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

Publications

  • Thyroid abnormalities are prevalent in primary Raynaud's phenomenon and thyroid-directed therapy may improve response to Raynaud's treatment [Meeting Abstract]

    Mazori, D R; Femia, A N
    Journal of investigative dermatology. 2015 May 2015. 135: S50-S50

  • Adult-onset linear morphea is associated with significant morbidity and methotrexate may reduce risk of disease reactivation [Meeting Abstract]

    Mazori, D R; Wright, N A; Patel, M; Ramachandran, S; Franks, A G; Vleugels, R; Femia, A N
    Journal of investigative dermatology. 2015 May 2015. 135: S48-S48

  • Progressive necrobiosis lipoidica of the bilateral breasts successfully treated with systemic corticosteroids, methotrexate, and pentoxifylline [Meeting Abstract]

    Wright, N A; Mazori, D R; Patel, M; Nambudiri, V E; Femia, A N; Vleugels, R
    Journal of investigative dermatology. 2015 May 2015. 135: S42-S42

Read All Publications (15)